backProgram Speaker
Bev Lorell, Michael Petty, and Wick Sollers
Description
Join us for a discussion on federal enforcement trends regarding scrutiny on clinical research and uses of the data. We will examine the expanding and increasingly sophisticated "clinical research tool box" used by the DOJ in False Claims Act investigations. Learn how federal enforcement is using analyses of: (1) clinical study design and conduct; (2) uses and misuses of clinical data by companies and investigators – including peer reviewed publications; and (3) disclosures about ongoing clinical trials. Consider how upcoming Sunshine Act "big data" may impact this scrutiny. We also discuss practical tactics to identify and mitigate potential risks.
You may register for the program here.
If you have questions that are not addressed during the program, please contact one of the speakers and they will be happy to answer them.
If you would like to receive CLE credit for this program, please complete this linked form and return to King & Spalding (see instructions on form).
Thank you for your interest in our e-Learn Pharma Series. To send a request to have your name placed on the e-Learn invitation list, click here.
Contact
Barbara Geier
Professional Development Manager
King & Spalding LLP
1180 Peachtree Street NE
Atlanta, GA 30309
+1 404 572 4924 Direct
bgeier@kslaw.com